Add a Comment By Eva Kiesler, PhD, Science Writer/Editor   |  Thursday, November 20, 2014 In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system. read more

View original post here:
New Findings Clarify How Immunotherapy Works — and Why, In Some People, It Doesn’t

Scroll to Top